-
Surgalign in the news: 3 updates
Here are three updates on Surgalign, a medical technology company, that Becker's has reported on since March 1: -
NuVasive marks 20th year of XLIF procedure
NuVasive reached the 20-year milestone with the extreme lateral interbody fusion, the devicemaker said March 13. -
Surgalign launches Holo AI Insights for spine surgery
Surgalign released Holo AI Insights to assist clinical decision-making in spine surgery, the medtech company said March 13. -
Augmedics adds new features, indications for AR spine system
Augmedics' Xvision system for spine surgery can now be used for cervical and iliosacral cases, the medtech company said March 8. -
Two Neurosurgeons and Their Thoughts on Medtronic’s CD Horizon™ ModuLeX™ 5.5 Spinal System
Medtronic’s CD Horizon™ ModuLeX™ 5.5 Spinal System has been developed as a headless in-situ modular attachment solution to offer increased visualization of the surgical working area compared to a pre-assembled screw, and the ability to intraoperatively assemble solutions to meet a wide variety of treatment goals. The CD Horizon™ ModuLeX™ 5.5 Spinal System is compatible with all 5.5 rods within the CD Horizon™ product family and is integrated for use with Medtronic’s advanced surgical technologies, including O-arm™ imaging, StealthStation™ navigation systems and Powerease™ System -
Proprio introduces surgical navigation system into operating rooms
Proprio has introduced its flagship system, Paradigm, into operating rooms around the U.S. -
ZimVie to partner with Brainlab for spine portfolio
ZimVie, Zimmer Biomet's spinoff company, plans to use a new partnership to strengthen its spine business, President and CEO Vafa Jamali said in a March 1 earnings call. -
Texas hospital adds Holo Portal spine system
Medical City Frisco (Texas), an HCA Healthcare affiliate, has added Surgalign's Holo Portal Surgical Navigation System for lumbar spine procedures to its clinical toolkit. -
Aurora Spine to launch study for color-coded cervical implants
Aurora Spine earned Institutional Review Board approval to begin a multicenter study of its Dexa-C cervical interbody system, the devicemaker said March 2. -
ZimVie sees $30.3M net loss in Q4: 5 notes
ZimVie on March 1 posted its fourth quarter and 2022 financial results. -
Alphatec sees 44% revenue jump in 2022 sales: 5 notes
Alphatec on Feb. 28 posted record sales growth for the fourth quarter and full year of 2022. -
Surgalign sells spine portfolio for $17M
Xtant Medical has acquired Surgalign's Coflex product line for $17 million. -
Dr. Chad Campion completes 1st case combining 7D Flash and Firebird spinal fixation systems
Chad Campion, MD, a spine surgeon at Baptist Memorial Hospital in Memphis, Tenn., was the first surgeon to used the 7D Flash navigation system in combination with the Firebird spinal fixation system, devicemaker Orthofix said in a Feb. 25 LinkedIn post. -
FloSpine's 3D-printed cervical spine implant earns FDA nod
FloSpine's 3D-printed Ti-Largo earned FDA 510(k) clearance, the devicemaker said Feb. 28. -
NuVasive's Pulse platform surpasses 2,000 cases
NuVasive's Pulse spine platform surpassed 2,000 commercial cases since it was released in 2021, CEO Chris Barry said in a fourth-quarter earnings call. -
Globus Medical, NuVasive see $1B+ in 2022 ahead of merger
Globus Medical and NuVasive both raked in more than $1 billion in 2022 revenue, along with fourth quarter sales increases ahead of their planned merger. -
Stryker vs. Johnson & Johnson vs. Zimmer Biomet: How they compare in Q4
Stryker, Johnson & Johnson and Zimmer Biomet posted their fourth quarter financial results, and data on their orthopedic sales. -
Non-screw-based lateral cage system earns FDA approval
Spinal implant company Expanding Innovations has received FDA 510(k) clearance for its X-Pac Expandable Lateral Cage System, a non-screw-based implant that addresses the core principles of lateral lumbar interbody fusion. -
NuVasive's cervical interbody implant earns additional FDA indications
NuVasive's Modulus cervical interbody implant was approved by the FDA for use with a bone void filler, the devicemaker said Feb. 21. -
Medtronic sees $1.1B in spine sales during Q3 of fiscal year 2023
Medtronic on Feb. 21 posted $7.7 billion in revenue during the third quarter of fiscal year 2023.
Page 31 of 201